🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07714109
Active, not recruiting Observational

Twelve-lead Wearable Holter,MRI,CT,X-ray,Echocardiography

NCT07714109 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Observational
Started
2025-12-18
Last updated
2026-07-20

Condition(s) studied

Cardiac Arrhythmia

Study summary

The 12-lead wearable Holter monitor is compatible with most examinations including MRI, CT, X-ray and echocardiography without compromising data quality. It helps shorten patients' medical visit duration and improves the detection rate of arrhythmias.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Aged ≥18 years old; 2. Patients requiring MRI, CT, X-ray or cardiac ultrasound examination; 3. Voluntarily wear the 12-lead wearable ambulatory electrocardiography device during imaging examination; 4. Able to understand and sign the informed consent form independently. Exclusion Criteria: 1. Severe skin damage, infection or allergy on chest skin unable to attach ECG electrodes; 2. Unstable critical condition, emergency rescue state; 3. Permanent magnet-containing implantable devices incompatible with magnetic resonance; 4. Mental disorders or cognitive dysfunction unable to cooperate with examination; 5. Pregnant women.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07714109 on ClinicalTrials.gov ↗ ← All trials in China